Medical Marijuana, Inc.’s HempMeds® Spokesperson Penny Howard Sees Daughter Harper’s Legacy at UCSD on What Would Have Been Her 6th Birthday

Harper Howard’s Parents Witness Her Contribution to CDKL5 Research; Harper’s Brain Cells Being Grown by Dr. Muotri, Lead Stem Cell Researcher at Univ. of Calif. San Diego School of Medicine

SAN DIEGO, April 07, 2016 (GLOBE NEWSWIRE) -- The tragic loss of Harper Howard on Jan. 8 stunned those who followed her journey battling CDKL5 epilepsy, however her bold spirit lives on. Through Harper’s donation of the world’s first 28-month daily cannabis use brain for CDKL5 research, although she is no longer with us, her cells are – and they are growing under the watchful eye of Dr. Alysson Muotri at UCSD medical research laboratory in San Diego.

On April 12, what would have been Harper’s 6th birthday, Penny and Dustin Howard will witness their daughter’s massive contribution to science at Dr. Muotri’s laboratory.

“Harper would want people to know,” states Penny Howard, Harper’s mother, co-founder of and spokesperson for Medical Marijuana, Inc.'s (OTC:MJNA) HempMeds®.  “Throughout her five-year battle with CDKL5 epilepsy, Harper achieved so many milestones and, as a daily hemp cannabidiol (CBD) oil consumer, she became a shining example of what the ‘new normal’ can be for special needs children. Harper’s living legacy is furthering science and medical research.”

Although Dr. Muotri is researching CDKL5 epilepsy, with Harper’s unique profile and tissue donation, San Diego can now add cannabis-affected brain cell research to the region’s resume.  Dr. Muotri’s research includes testing Harper’s brain cells with other drugs as well as the cannabinoid CBD.

Howard continues, “Harper’s brain cells are providing a platform for researchers to seek a cure for CDKL5 epilepsy and other seizure-related disorders. Witnessing Harper’s new place in the world of medical research is helping our family to gain closure. We are grateful to Dr. Muotri for opening both his heart and laboratory to us on what would have been Harper’s 6th birthday. We miss our daughter and our children, Lily and Seth, miss their sister every day. Seeing Harper’s life benefit mankind in this way is comforting for all of us.”

Harper’s life achievements – including becoming the National American Miss Princess Cover Girl for the state of Texas – is chronicled on and in an article published by the Huffington Post. The Facebook blog became a catalyst for the historic decision of the Brazilian government to both import Medical Marijuana, Inc.’s Real Scientific Hemp Oil™ (RSHO™) – and also subsidize payments for RSHO™ under the Brazilian government’s health care system.

For more information on HempMeds® and their all-natural hemp oil products, visit: The Company invites the public to get involved in the conversation of the expanding cannabis industry with HempMeds® through the Company’s social media websites on Facebook and Twitter.

About HempMeds®
HempMeds® offers mainstream marketing, sales, customer service, and logistics for the cannabis industry. HempMeds® is a corporate portfolio company of Medical Marijuana, Inc. (OTC Pink:MJNA) and the Company’s exclusive master distributor and contracted marketing company. In addition to handling sales and distribution, HempMeds® is the communication hub for the Medical Marijuana Inc. portfolio of companies.

About Medical Marijuana Inc.
Our mission is to be the premier cannabis and hemp industry innovators, leveraging our team of professionals to source, evaluate and purchase value-added companies and products, while allowing them to keep their integrity and entrepreneurial spirit. We strive to create awareness within our industry and develop environmentally-friendly, economically sustainable businesses, while increasing shareholder value. For details on Medical Marijuana, Inc.’s portfolio and investment companies, visit

The Company is committed to consistently providing the highest-quality CBD hemp oil products on the market. To see Medical Marijuana, Inc.’s video statement, click here. Shareholders are also encouraged to visit the Medical Marijuana, Inc. Shop for discounted products.

This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Medical Marijuana, Inc. to be materially different from the statements made herein.

These statements have not been evaluated by the FDA and are not intended to diagnose, treat or cure any disease.

Medical Marijuana Inc. and HempMeds do not sell or distribute any products that are in violation of the United States Controlled Substances Act (US.CSA). These companies do grow, sell, and distribute hemp-based products and are involved with the federally legal distribution of medical marijuana-based products within certain international markets. Cannabidiol is a natural constituent of hemp oil.

For further information, please contact:

Public Relations contact:

Andrew Hard
CMW Media
P. 888-829-0070

Corporate contact:
Medical Marijuana, Inc.
Toll Free: 888-OTC-MJNA (888-682-6562)

Investor Relations:
Nicholas R. Massalas
Director of Business Development
Medical Marijuana Inc.
OTC Symbol: MJNA 

Toll Free: (877) 964.6463
Direct: (858) 264-6505